Literature DB >> 25537696

Pediatric pain management in palliative care.

Julia Downing1, Satbir Singh Jassal, Lulu Mathews, Hanneke Brits, Stefan J Friedrichsdorf.   

Abstract

The management of pain in pediatric palliative care (PPC) is essential. Whilst the field of pain management has developed over the years, much of what is done in PPC is based on anecdotal evidence or adult studies. This review explores recent developments in pain management in PPC, in particular the WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses. Key issues discussed include the definition, assessment, pharmacological and integrative management of pain, availability of medications, education and research. Whilst advances have been made, including publication of the guidelines, significant gaps exist in terms of the evidence base, education and access to essential medications and both interdisciplinary and international collaboration are required to meet these gaps.

Entities:  

Keywords:  global; integrative; nonpharmacological; pain; pain assessment; pain guidelines; pain management; pediatric; pharmacological; public health

Mesh:

Year:  2015        PMID: 25537696     DOI: 10.2217/pmt.14.45

Source DB:  PubMed          Journal:  Pain Manag        ISSN: 1758-1869


  8 in total

1.  Symptoms and Concerns Among Children and Young People with Life-Limiting and Life-Threatening Conditions: A Systematic Review Highlighting Meaningful Health Outcomes.

Authors:  Eve Namisango; Katherine Bristowe; Matthew J Allsop; Fliss E M Murtagh; Melanie Abas; Irene J Higginson; Julia Downing; Richard Harding
Journal:  Patient       Date:  2019-02       Impact factor: 3.883

2.  Use of buccal morphine in the management of pain in children with life-limiting conditions: Results of a laboratory study.

Authors:  Renée McCulloch; Mohammed Sattar; Ellen M Henderson; Majella E Lane; Myra Bluebond-Langner
Journal:  Palliat Med       Date:  2017-06-20       Impact factor: 4.762

3.  Nursing-Related Barriers to Children's Pain Management at Selected Hospitals in Ghana: A Descriptive Qualitative Study.

Authors:  Abigail Kusi Amponsah; Evans Frimpong Kyei; John Bright Agyemang; Hanson Boakye; Joana Kyei-Dompim; Collins Kwadwo Ahoto; Evans Oduro
Journal:  Pain Res Manag       Date:  2020-01-20       Impact factor: 3.037

4.  Priorities for global research into children's palliative care: results of an International Delphi Study.

Authors:  Julia Downing; Caprice Knapp; Mary Ann Muckaden; Susan Fowler-Kerry; Joan Marston
Journal:  BMC Palliat Care       Date:  2015-08-04       Impact factor: 3.234

5.  Children's palliative care now! Highlights from the second ICPCN conference on children's palliative care, 18-21 May 2016, Buenos Aires, Argentina.

Authors:  J Downing; R Kiman; S Boucher; B Nkosi; B Steel; C Marston; E Lascar; J Marston
Journal:  Ecancermedicalscience       Date:  2016-08-23

6.  Qualitative Analysis of Palliative Care for Pediatric Patients With Cancer at Bugando Medical Center: An Evaluation of Barriers to Providing End-of-Life Care in a Resource-Limited Setting.

Authors:  B Emily Esmaili; Kearsley A Stewart; Nestory A Masalu; Kristin M Schroeder
Journal:  J Glob Oncol       Date:  2018-07

7.  Final Year Nursing Students' Knowledge and Attitudes regarding Children's Pain.

Authors:  Abigail Kusi Amponsah; Joana Kyei-Dompim; Evans Frimpong Kyei; Evans Oduro; Richard Adongo Afaya; Collins Kwadwo Ahoto
Journal:  Pain Res Manag       Date:  2020-02-13       Impact factor: 3.037

8.  Practical Approaches and Knowledge Gaps in the Care for Children With Leukodystrophies.

Authors:  Stephanie R Keller; Eric J Mallack; Jennifer P Rubin; Jennifer A Accardo; Jennifer A Brault; Camille S Corre; Camila Elizondo; Jennifer Garafola; April C Jackson-Garcia; Jullie Rhee; Elisa Seeger; Kaprice C Shullanberger; Amanda Tourjee; Melissa K Trovato; Amy T Waldman; Jenna L Wallace; Michael R Wallace; Klaus Werner; Angela White; Kevin C Ess; Catherine Becker; Florian S Eichler
Journal:  J Child Neurol       Date:  2020-09-02       Impact factor: 1.987

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.